---
$id: https://graph.org.ai/products/commodity/51131812
$type: Product
source: UNSPSC
code: "51131812"
title: "Romiplostim"
class: "51131800"
classTitle: "Coagulants and systemic hemostatic agents"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Romiplostim

**UNSPSC Code**: 51131812
**Class**: [Coagulants and systemic hemostatic agents](Coagulants and systemic hemostatic agents.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic colony stimulating factor with the molecular formula C1317H2043N361O395S9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GN5XU2DXKV, more generally known as romiplostim. European Medicines Agency schedules romiplostim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27756. The term ROMIPLOSTIM is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 22, no. 1, 2008, list 59. As of Q4 2014, ROMIPLOSTIM remains the US FDA Preferred Term for this commodity.

